Eli Lilly Reveals Receipt Of Subpoena From DoJ On Branchburg Manufacturing Facility - Quick Facts

Drug maker Eli Lilly and Co. (LLY) on Thursday revealed in a Form 8-K filing with the U.S. Securities and Exchange Commission that it received a subpoena from the U.S. Department of Justice requesting the production of certain documents relating to its manufacturing site in Branchburg, New Jersey. Lilly said it is cooperating fully with the investigation.

Lilly said it had previously engaged external counsel to conduct an independent investigation of certain allegations relating to the Branchburg facility. Lilly, through its counsel, is investigating these allegations thoroughly.

Lilly noted that it is deeply committed to manufacturing high-quality medicines for patients who need them, and the safety and quality of our products is our highest priority.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
After Disney World, retail giant Walmart Inc. (WMT) makes it mandatory for all its employees to wear mask on their facilities in the "high-risk" states where the Delta variant of Coronavirus has become menacing. The orders will be in effect immediately. The Center for Disease Control and Prevention... Generac Power Systems is recalling 325,735 units of Generac and DR 6500 Watt and 8000 Watt portable generators for potential risk of finger amputation and crushing hazards, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. These include 4,575 units sold in Canada. Omaha, Nebraska- based Greater Omaha Packing is recalling around 295,236 pounds of raw beef products citing the possible presence of E. coli O157:H7, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The raw beef products intended for non-intact use were produced on July 13.
Follow RTT